Oxidized low density lipoproteins activate CD4+ T cell apoptosis in patients with end-stage renal disease through Fas engagement (vol 18, pg 331, 2007)

被引:2
|
作者
Meier, P.
Spertini, F.
Blanc, E.
Burnier, M.
机构
来源
关键词
D O I
10.1681/ASN.2014010004
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:645 / 645
页数:1
相关论文
共 7 条
  • [1] RETRACTED: Oxidized low-density lipoproteins activate CD4+ T cell apoptosis in patients with end-stage renal disease through Fas engagement (Retracted Article)
    Meier, Pascal
    Spertini, Francois
    Blanc, Edouard
    Burnier, Michel
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (01): : 331 - 342
  • [2] Apoptosis of Peripheral CD4+ T-Lymphocytes in End-Stage Renal Disease Patients Under Hemodialysis and rhEPO Therapies
    Borges, Ana
    Borges, Margarida
    Fernandes, Joao
    Nascimento, Henrique
    Sameiro-Faria, Maria
    Miranda, Vasco
    Reis, Flavio
    Belo, Luis
    Costa, Elisio
    Santos-Silva, Alice
    RENAL FAILURE, 2011, 33 (02) : 138 - 143
  • [3] End-stage renal disease, dialysis, kidney transplantation and their impact on CD4+ T-cell differentiation
    Schaier, Matthias
    Leick, Angele
    Uhlmann, Lorenz
    Kaelble, Florian
    Morath, Christian
    Eckstein, Volker
    Ho, Anthony
    Mueller-Tidow, Carsten
    Meuer, Stefan
    Mahnke, Karsten
    Sommerer, Claudia
    Zeier, Martin
    Steinborn, Andrea
    IMMUNOLOGY, 2018, 155 (02) : 211 - 224
  • [4] pERK-dependent defective TCR-mediated activation of CD4+ T cells in end-stage renal disease patients
    Huang, Ling
    Litjens, Nicolle H. R.
    Kannegieter, Nynke M.
    Klepper, Mariska
    Baan, Carla C.
    Betjes, Michiel G. H.
    IMMUNITY & AGEING, 2017, 14
  • [5] pERK-dependent defective TCR-mediated activation of CD4+ T cells in end-stage renal disease patients
    Ling Huang
    Nicolle H. R. Litjens
    Nynke M. Kannegieter
    Mariska Klepper
    Carla C. Baan
    Michiel G. H. Betjes
    Immunity & Ageing, 14
  • [6] Dysregulation of IL-2/IL-2R system alters proliferation of early activated CD4+ T cell subset in patients with end-stage renal failure
    Meier, P
    Dayer, E
    Ronco, R
    Blanc, E
    CLINICAL NEPHROLOGY, 2005, 63 (01) : 8 - 21
  • [7] Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts (vol 12, pg 325, 2007)
    Mocroft, Amanda
    Staszewski, Schlomo
    Weber, Rainer
    Gatell, Jose
    Rockstroh, Jurgen
    Gasiorowski, Jacek
    Panos, George
    Monforte, Antonella d'Arminio
    Rakhmanova, Aza
    Phillips, Andrew N.
    Lundgren, Jens D.
    ANTIVIRAL THERAPY, 2007, 12 (04) : 577 - 577